US clinics acquired from Novamind demonstrating continued growth Physical rebranding of clinics is underway Announcing new client financing options in Canada VANCOUVER, BC, Sept. 13, 2022 /PRNewswire/ – Numinus Wellness Inc. (“Numinus”, the “Company”) (TSX: NUMI) ( OTCQX: NUMIF) is pleased to provide an update on the integration of the Novamind acquisition, which completed on June 10, 2022.


Previous articleNature Biotechnology Selects Delix Therapeutics as a Leading Biotech Start-Up
Next articleRevive Therapeutics Announces Submission of Amended Phase 3 COVID-19 Study Protocol to FDA